Federated Hermes’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3
| Closed | -$71 | – | 2175 |
|
|
2023
Q4 | $71 | Buy |
+3
| New | +$71 | ﹤0.01% | 2031 |
|
|
2022
Q1 | – | Sell |
-77,403
| Closed | -$262K | – | 2360 |
|
|
2021
Q4 | $262K | Buy |
77,403
+77,361
| +184,193% | +$262K | ﹤0.01% | 1599 |
|
|
2021
Q3 | $1K | Sell |
42
-481
| -92% | -$11.5K | ﹤0.01% | 2177 |
|
|
2021
Q2 | $2K | Sell |
523
-306
| -37% | -$1.17K | ﹤0.01% | 2105 |
|
|
2021
Q1 | $4K | Buy |
829
+504
| +155% | +$2.43K | ﹤0.01% | 2084 |
|
|
2020
Q4 | $2K | Sell |
325
-24
| -7% | -$148 | ﹤0.01% | 2138 |
|
|
2020
Q3 | $3K | Sell |
349
-168
| -32% | -$1.44K | ﹤0.01% | 2081 |
|
|
2020
Q2 | $2K | Sell |
517
-124,522
| -100% | -$482K | ﹤0.01% | 2105 |
|
|
2020
Q1 | $185K | Buy |
125,039
+26,451
| +27% | +$39.1K | ﹤0.01% | 1585 |
|
|
2019
Q4 | $193K | Buy |
98,588
+62,185
| +171% | +$122K | ﹤0.01% | 1608 |
|
|
2019
Q3 | $186K | Buy |
36,403
+33,088
| +998% | +$169K | ﹤0.01% | 1594 |
|
|
2019
Q2 | $24K | Buy |
3,315
+2,883
| +667% | +$20.9K | ﹤0.01% | 1777 |
|
|
2019
Q1 | $6K | Buy |
+432
| New | +$6K | ﹤0.01% | 1958 |
|
|
2018
Q2 | – | Sell |
-172
| Closed | -$2K | – | 2289 |
|
|
2018
Q1 | $2K | Buy |
+172
| New | +$2K | ﹤0.01% | 2074 |
|
|
2017
Q3 | – | Sell |
-2,393
| Closed | -$14K | – | 2202 |
|
|
2017
Q2 | $14K | Buy |
2,393
+272
| +13% | +$1.59K | ﹤0.01% | 1787 |
|
|
2017
Q1 | $9K | Buy |
+2,121
| New | +$9K | ﹤0.01% | 1834 |
|